Glutathione transferases and neurodegenerative diseases

Neurochemistry International

Volumn 82, Issue , 2015, Pages 10-18

  Mazzetti, Anna Paola ^a   Fiorile, Maria Carmela ^a   Primavera, Alessandra ^a   Lo Bello, Mario ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Alzheimer's disease; Glutathione; Glutathione transferases; Oxidative stress; Parkinson's disease

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN;

AGE; AGING; ALZHEIMER DISEASE; ANTIOXIDANT RESPONSIVE ELEMENT; BRAIN; CEREBROSPINAL FLUID; CONJUGATION; CYTOSOL; DEGENERATIVE DISEASE; GLUTATHIONE METABOLISM; HUMAN; IN VITRO STUDY; LIPID PEROXIDATION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; ANIMAL MODEL; CHEMICAL STRUCTURE; DEFICIENCY; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN CONFORMATION;

ANIMALIA;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; MODELS, ANIMAL; MODELS, MOLECULAR; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION;

EID: 84922895406     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.01.008     Document Type: Review

References (149)

1. Abramovitz, M., Homma, H., Ishigaki, S., Tansey, F., Cammer, W., Listowsky, I., 1988. Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J. Neurochem. 50, 50-57.
2. Adler, V., Yin, Z., Fuchs, S.Y., Benezra, M., Rosario, L., Tew, K.D., et al., 1999. Regulation of JNK signaling by GSTp. EMBO J. 18, 1321-1334.
3. Ahmadi, A., Fredrikson, M., Jerregârd, H., Akerbäck, A., Fall, P.A., Rannug, A., et al., 1999. GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset. Biochem. Biophys. Res. Commun. 269, 676-680.
4. Andersen, J.K., Mo, J.Q., Hom, D.G., Lee, F.Y., Harnish, P., Hamill, R.W., et al., 1996. Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J. Neurochem. 67, 2164-2171.
5. Aniya, Y., Imaizumi, N., 2011. Mitochondrial glutathione transferases involving a new function for membrane permeability transition pore regulation. Drug Metab. Rev. 43, 292-299.
6. Ansari, M.A., Scheff, S.W., 2010. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J. Neuropathol. Exp. Neurol. 69, 155-167.
7. Aoyama, K., and Nakaki, T., 2013. Impaired glutathione synthesis in neurodegeneration. Int. J. Mol. Sci. 14, 21021-21044.
8. Arning, L., Jagiello, P., Wieczorek, S., Saft, C., Andrich, J., Epplen, J.T., 2004. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease. BMC Med. Genet. 24, 5-7.
9. Azam, F., Amer, A.M., Abulifa, A.R., Elzwawi, M.M., 2014. Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer's drugs: a computational investigation. Drug Des. Devel. Ther. 8, 2045-2059.
10. Baez, S., Segura-Aguilar, J., Widerstern, M., Johansson, A.S., Mannervik, B., 1997. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 324, 25-28.
11. Benson, A.M., Talalay, P., Keen, J.H., Jakoby, W.B., 1977. Relationship between the soluble glutathione-dependent delta 5-3-ketosteroid isomerase and the glutathione S-transferases of the liver, Proc. Natl. Acad. Sci. U.S.A. 74, 158-162.
12. Berezin, V., Walmod, P.S., Filippov, M., Dityatev, A., 2014. Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases. Prog. Brain Res. 214, 353-388.
13. Bernardini, S., Bellincampi, L., Ballerini, S., Federici, G., Iori, R., Trequattrini, A., et al., 2005. Glutathione S-transferase P1 ∗C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon 4 allele. Clin. Chem. 51, 944-951.
14. Beuckmann, C.T., Fujimori, K., Urade, Y., Hayaishi, O., 2000. Identification of mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain. Neurochem. Res. 25, 733-738.
15. Blackburn, A.C., Woollatt, E., Sutherland, G.R., Board, P.G., 1998. Characterization and chromosome location of the gene GSTZ1 encoding the human Zeta class glutathione transferase and maleylacetoacetate isomerase, Cytogenet. Cell Genet. 83, 109-114.
16. Board, P.G., 2011. The omega-class glutathione transferases: structure, function, and genetics. Drug Metab. Rev. 43, 226-235.
17. Board, P.G., Anders, M.W., 2011. Glutathione transferase Zeta: discovery, polymorphic variants, catalysis, inactivation and properties of GSTZ1-/- mice. Drug Metab. Rev. 43,215-225.
18. Board, P.G., Menon, D., 2013. Glutathione transferases, regulators of cellular metabolism and physiology. Biochim. Biophys. Acta 1830, 3267-3288.
19. 2+ release channels, Int. J. Biochem. Cell Biol. 36, 1599-1612.
20. Brigelius-Flohé R., Maiorino M., 2013. Glutathione peroxidases. Biochim. Biophys. Acta 1830, 3289-3303.
21. Butterfield, D.A., Reed, T., Newman, S.F., Sultana, R., 2007. Roles of amyloid beta-peptide- associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic. Biol. Med. 43, 658-677.
22. Cacciatore, I., Baldassarre, L., Fornasari, E., Mollica, A., Pinnen, F., 2012. Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. Oxid. Med. Cell. Longev. 2012, 1-12, Article ID 240146.
23. Calatozzolo, C., Pollo, B., Botturi, A., Dinapoli, L., Carosi, M., Salmaggi, A., Maschio, M., 2012. Multidrug resistance proteins expression in glioma patients with epilepsy. J. Neurooncol. 110, 129-135.
24. Cammer, W., Tansey, F., Abramovitz, M., Ishigaki, S., Listowsky, I., 1989. Differential localization of glutathione S-transferase Yp and Yb subunits in oligodendrocytes and astrocytes of rat brain. J. Neurochem. 52, 876-883.
25. Carder, P.J., Hume, R., Fryer, A.A., Strange, R.C., Lauder, J., Bell, J.E., 1990. Glutathione S-transferase in human brain. Neuropathol. Appl. Neurobiol. 16, 293-303.
26. Carvalho, A.N., Lim, J.L., Nijland, P.G., Witte, M.E., Van Horssen, J., 2014. Glutathione in multiple sclerosis: more than just an antioxidant? Mult. Scler. 20, 1425-1431.
27. Castro-Caldas, M., Carvalho, A.N., Rodrigues, E., Henderson, C., Wolf, C.R., Gama, M.J., 2012. Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway. Mol. Neurobiol. 45, 466-477.
28. Cesareo, E., Parker, L.J., Pedersen, J.Z., Nuccetelli, M., Mazzetti, A.P., Pastore, A., et al., 2005. Nitrosylation of human glutathione transferase P1-1 with dinitrosyl diglutathionyl iron complex in vitro and in vivo. J. Biol. Chem. 280, 42172-42180.
29. Chen, J., Liou, A., Zhang, L., Weng, Z., Gao, Y., Cao, G., et al., 2012. GSTP1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death. Front. Biosci. 4, 2365-2377.
30. Cho, S.G., Lee, Y.H., Park, H.S., Ryoo, K., Kang, K.W., Park, J., et al., 2001. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase1. J. Biol. Chem. 276, 12749-12755.
31. Ciccone, S., Maiani E., Bellusci, G., Diederich, M., Gonfloni, S., 2013. Parkinson's disease: a complex interplay of mitochondrial DNA alterations and oxidative stress. Int. J. Mol. Sci. 14, 2388-2409.
32. Currais, A., Maher, P., 2013. Functional consequences of age-dependent changes in glutathione status in the brain. Antioxid. Redox Signal. 19 813-822.
33. Dagnino-Subiabre, A., Cassels, B.K., Baez, S., Johansson, A.-S., Mannervik, B., Segura-Aguilar, J., 2000. Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. Biochem. Biophys. Res. Commun. 274, 32-36.
34. De Luca, A., Moroni, N., Serafino, A., Primavera, A., Pastore, A., Pedersen, J.Z., et al., 2011. Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance. Biochem. J. 440, 175-183.
35. Deng, Y., Newman, B., Dunne, M.P., Silburn, P.A., Mellick, G.D., 2004. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Neurosci. Lett. 366, 326-331.
36. Di Monte, D.A., Chan, P., Sandy, M.S., 1992. Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? Ann. Neurol. 32, S111-S115.
37. Dickinson, D.A., Forman, H.J., 2002. Glutathione in defense and signaling: lessons from a small thiol. Ann. N. Y. Acad. Sci. 973, 488-504.
38. Dieckhaus, C.M., Roller, S.G., Santos, W.L., Duane Sofia, R., and Macdonald, T.M., 2001. Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite. Chem. Res. Toxicol. 14, 511-516.
39. Dorion, S., Lambert, H., Landry, J., 2002. Activation of the p38 signaling pathway by heatshock involves the dissociation of glutathione S-transferase Mu from Ask1. J. Biol. Chem. 277, 30792-30797.
40. Dringen, R., 2000. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62, 649-671.
41. Dringen, R., Hirrlinger, J., 2003. Glutathione pathways in the brain. Biol. Chem. 384, 505-516.
42. Dringen, R., Gutterer, J.M., and Hirrlinger, J., 2000. Glutathione metabolism in brain. Metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267, 4912-4916.
43. Dringen, R., Brandmann, M., Hohnholt, M.C., Blumrich, E.M., 2014. Glutathione-dependent detoxification processes in astrocytes. Neurochem Res. 2014 Nov 27. [Epub ahead of print]
44. Dulhunty, A., Gage, P., Curtis, S., Chelvanayagam, G., and Board, P. 2001. The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J. Biol. Chem. 276,3319-3323.
45. Elsby, R., Kitteringham, N.R., Goldring, C.E., Lovatt, C.A., Chamberlain, M., Henderson, C.J., et al., 2003. Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi, J. Biol. Chem. 278, 22243-22249.
46. Farr, S.A., Ripley, J.L., Sultana, R., Zhang, Z., Niehoff, M.L., Platt, T.L., et al., 2014. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radic. Biol. Med. 67, 387-395.
47. Flohé, L., 2013. The fairytale of the GSSG/GSH redox potential. Biochim. Biophys. Acta 1830 3139-3142.
48. Fratelli, M., Demol, H., Puype, M., Casagrande, S., Villa, P., Eberini, I., et al., 2003. Identification of proteins undergoing glutathionylation in oxidatively stressed hepatocytes and hepatoma cells. Proteomics 3, 1154-1161.
49. García-Giménez, J.L., Markovic, J., Dasí, F., Queval, G., Schnaubelt, D., Foyer, C.H., et al., 2013. Nuclear glutathione. Biochim. Biophys. Acta 1830, 3304-3316.
50. Garcia-Garcia, A., Zavala-Flores, L., Rodriguez-Rocha, H., Franco, R., 2012. Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease. Antioxid. Redox Signal. 17, 1764-1784.
51. Ghosh, T., Mustafa, M.D., Kumar, V., Datta, S.K., Bhatia, M.S., Sircar, S., et al., 2012. A preliminary study on the influence of glutathione S transferase T1 (GSTT1) as a risk factor for late onset Alzheimer's disease in North Indian population. Asian J. Psychiatr. 5:160-163.
52. Gong, G., O'Bryant, S.E., 2010. The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 24, 311-316.
53. Habig, W.H., Jakoby, W.B., 1981. Glutathione S-transferases (rat and human). Methods Enzymol. 77, 218-231.
54. Harish, G., Mahadevan, A., Srinivas Bharath, M.M., Shankar, S.K., 2013. Alteration in glutathione content and associated enzyme activities in the synaptic serminals but not in the non-synaptic mitochondria from the frontal cortex of Parkinson's disease brains. Neurochem. Res. 38,186-200
55. Hayes, J.D., Flanagan, J.U., Jowsey, I.R., 2005. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51-88.
56. Higgins, L.G., and Hayes, J.D., 2011. Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and proinflammatory agents Drug Metab. Rev., 43, 92-137.
57. Hubatsch, I., Ridderstrom. M., Mannervik, B., 1998. Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem. J. 330,175-179.
58. Hurst, R., Bao, Y., Jemth, P., Mannervik, B., Williamson, G., 1998. Phospholipid hydroperoxide glutathione peroxidase activity of human glutathione transferases. Biochem. J. 332, 97-100.
59. Isopi, E., Granzotto, A., Corona, C., Bomba, M., Ciavardelli, D., Curcio, M., et al., 2014. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology. Neurobiol. Dis.: S969-S9961.
60. Jakobsson, P.J., Morgenstern, R., Mancini, J., Ford-Hutchinson, A., Persson, B., 1999. Common structural features of MAPEG - a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci. 8, 689-692.
61. Jenner, P., Dexter, D.T., Sian, J., Schapira, A.H., Marsden, C.D., 1992. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 32, S82-S87.
62. Jha, R., Rizvi, S.I., 2009. Age-dependent decline in erythrocyte acetylcholinesterase activity: correlation with oxidative stress. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 153, 195-198.
63. Johansson, A.S., Mannervik, B., 2002. Active-site residues governing high steroid isomerase activity in human glutathione transferase A3-3, J. Biol. Chem. 277, 16648-16654.
64. Jowsey, I.R., Thomson, A.M., Flanagan, J.U., Murdock, P.R., Moore, G.B., Meyer, D.J., et al., 2001. Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases, Biochem. J. 359, 507-516.
65. Kang, Y., Viswanath, V., Jha, N., Qiao, X., Mo, J.Q., Andersen, J.K., 1999. Brain gamma-glutamyl cysteine synthetase (GCS) mRNA expression patterns correlate with regional-specific enzyme activities and glutathione levels. J. Neurosci. Res. 58, 436-441.
66. Kazmierczak, B., Kuzma-Kozakiewicz, M., Usarek, E., Baranczyk-Kuzma, A., 2011. Differences in glutathione S-transferase pi expression in transgenic mice with symptoms of neurodegeneration. Acta Biochim. Pol. 58,621-626.
67. Kosenko, E.A., Aliev, G., Tikhonova, L.A., Li, Y., Poghosyan, A.C., Kaminsky, Y.G., 2012. Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers. CNS Neurol. Disord. Drug Targets 11, 926-932.
68. Kölsch, H., Linnebank, M., Lütjohann, D., Jessen, F., Wüllner, U., Harbrecht, U., et al., 2004. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology 63, 2255-2260.
69. Li, Y.J., Oliveira, S.A., Xu, P., Martin, E.R., Stenger, J.E., Scherzer, C.R., et al., 2003. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum. Mol. Genet. 12, 3259-3267.
70. Lim, C.E., Matthaei, K.I., Blackburn, A.C., Davis, R.P., Dahlstrom, J.E., Koina, M.E., et al., 2004. Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu and pi class glutathione transferases. Am. J. Pathol. 165, 379-393.
71. Listowsky, I., 2005. Proposed intracellular regulatory functions of glutathione transferases by recognition and binding to S-glutathiolated proteins. J. Pept. Res. 65, 42-46.
72. Litwack, G., Ketterer, B., Arias, I.M., 1971. Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature 234, 466-467.
73. Liu, D., Hewawasam, R., Pace, S.M., Gallant, E.M., Casarotto, M.G., Dulhunty, A.F., et al., 2009. Dissection of the inhibition of cardiac ryanodine receptors by human glutathione transferase GSTM2-2, Biochem. Pharmacol. 77 (2009) 1181-1193.
74. Lo Bello, M., Nuccetelli, M., Caccuri, A.M., Stella, L., Parker, M.W., Rossjohn, J., et al., 2001. Human glutathione transferase P1-1 and nitric oxide carriers; a new role for an old enzyme. J. Biol. Chem. 276, 42138-42145.
75. Longo, G.S., Pinhel, M.S., Sado, C.L., Gregório, M.L., Amorim, G.S., Florim, G.S., et al., 2013. Exposure to pesticides and heterozygote genotype of GSTP1-Alw26I are associated to Parkinson's disease. Arq. Neuropsiquiatr 71, 446-452.
76. Lovell, M.A., Xie, C., Markesbery, W.R., 1998. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566.
77. Maarouf, C.L., Beach, T.G., Adler, C.H., Shill, H.A., Sabbagh, M.N., Wu, T., et al., 2012. Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects. Neurol. Res. 34, 669-676.
78. Maher, A., El-Sayed, N.S., Breitinger, H.G., Gad, M.Z., 2014. Overexpression of NMDAR2B in an inflammatory model of Alzheimer's disease: modulation by NOS inhibitors. Brain Res. Bull. 109,109-116.
79. Manevich, Y., Feinstein, S.I., and Fisher A.B., 2003. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with πGST. PNAS, 101, 3780-3785
80. Marco, A., Cuesta, A., Pedrola, L., Palau, F., Marín, I., 2004. Evolutionary and structural analyses of GDAP1, involved in Charcot-Marie-Tooth disease, characterize a novel class of glutathione transferase-related genes. Mol. Biol. Evol. 1, 176-187.
81. Marí, M., Morales, A., Colell, A., García-Ruiz, C., Kaplowitz, N., Fernández-Checa, J.C., 2013. Mitochondrial glutathione: features, regulation and role in disease. Biochim. Biophys. Acta 1830, 3317-3328.
82. Markesbery, W.R., 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 1, 134-147.
83. Martin, H.L., Teismann, P., 2009. Glutathione - a review on its role and significance in Parkinson's disease. FASEB J. 23, 3263-3272.
84. Meister, A., Anderson, M.E., 1983. Glutathione. Annu. Rev. Biochem. 52, 711-760.
85. Morel, F., Aninat, C., 2011. The glutathione transferase kappa family. Drug Metab. Rev. 43, 281-291.
86. Morgenstern, R., Zhang, J., Johansson,K., 2011. Microsomal glutathione transferase 1. Mechanism and functional roles, Drug Metab. Rev. 43, 300-306.
87. Morozova, N., Khrapko, K., Panee, J., Liu, W., Harney, J.W., Berry, M.J., 2007. Glutathione depletion in hippocampal cells increases levels of H and L ferritin and glutathione S-transferase mRNAs. Genes Cells 12, 561-567.
88. Muyderman, H., Nilsson, M., Sims, N.R., 2004. Highly selective and prolonged depletion of mitochondrial glutathione in astrocytes markedly increases sensitivity to peroxynitrite. J. Neurosci. 24, 8019-8028.
89. Nicole, A., Santiard-Baron, D., Ceballos-Picot, I., 1998. Direct evidence for glutathione as mediator of apoptosis in neuronal cells. Biomed. Pharmacother. 52, 349-355.
90. Oakley, A., 2011. Glutathione transferases: a structural perspective. Drug Metab. Rev. 43, 138-151.
91. Otto, R., Penzis, R., Gaube, F., Winckler, T., Appenroth, D., Fleck, C., et al., 2014. Beta and gamma carboline derivatives as potential anti-Alzheimer agents: a comparison. Eur. J. Med. Chem. 87, 63-70.
92. Owen, A.D., Schapira, A.H., Jenner, P., Marsden, C.D., 1996. Oxidative stress and Parkinson's disease. Ann. N. Y. Acad. Sci. 786, 217-223.
93. Parker L.J., Ascher, D.B., Gao, C., Miles, L.A., Harris, H.H., Parker, M.W., 2012. Structural approaches to probing metal interaction with proteins. J. Inorg. Biochem. 115, 138-147.
94. Pearce, R.K., Owen, A., Daniel, S., Jenner, P., Marsden, C.D., 1997. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transm. 104, 661-667.
95. Perez-Pastene, C., Graumann, R., Díaz-Grez, F., Miranda, M., Venegas, P., Godoy, O.T., et al., 2007. Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component. Neurosci. Lett. 418(2):181-185.
96. Piacentini, S., Polimanti, R., Squitti, R., Ventriglia, M., Cassetta, E., Vernieri, F., et al., 2012a. GSTM1 null genotype as risk factor for late-onset Alzheimer's disease in Italian patients. J. Neurol. Sci. 317, 137-140.
97. Piacentini, S., Polimanti, R., Squitti, R., Mariani, S., Migliore, S., Vernieri, F., et al., 2012b. GSTO1∗E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant. Neurosci. Lett. 506, 203-207.
98. Pinhel, M.A., Nakazone, M.A., Cação, J.C., Piteri, R.C., Dantas, R.T., Godoy, M.F., et al., 2008. Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin. Chem. Lab. Med. 46, 439-445.
99. Pinhel. M.A., Sado, C.L., Longo Gdos, S., Gregório, M.L., Amorim, G.S., Florim, G.M., et al., 2013. Nullity of GSTT1/GSTM1 related to pesticides is associated with Parkinson's disease. Arq. Neuropsiquiatr. 71:527-532.
100. Pocernich, C.B., La Fontaine, M., Butterfield, D.A., 2000. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem. Int. 36, 185-191.
101. Polekhina, G., Board, P.G., Blackburn, A.C., and Parker, M.W., 2001. Crystal structure of maleylacetoacetate isomerase/glutathione transferase zeta reveals the molecular basis for its remarkable catalytic promiscuity. Biochemistry, 40, 1567-1576.
102. Polidori, M.C., Griffiths, H.R., Mariani, E., Mecocci, P., 2007. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease. Amino Acids 32, 553-559.
103. Popov, D., 2014. Protein S-glutathionylation: from current basics to targeted modifications. Arch. Physiol. Biochem. 12,1-8.
104. Prabhu, K.S., Reddy, P.V., Jones, E.C., Liken, A.D., Reddy, C.C., 2004. Characterization of a class alpha glutathione S-transferase with glutathione peroxidase activity in human liver microsomes. Arch. Biochem. Biophys. 424, 72-80.
105. Raichle, M.E., Gusnard, D.A., 2002. Appraising the brain's energy budget. Proc. Natl. Acad. Sci. U.S.A. 99, 10237-10239.
106. Reitz, C., Cheng, R., Schupf, N., Lee, J.H., Mehta, P.D., Rogaeva, E., et al., 2012. Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels. Neurobiol. Aging 33, 199.e13-7.
107. Rigsby, R.E., Fillgrove, K.L., Beihoffer, L.A., Armstrong R.N., 2005. Fosfomycin resistance proteins: a nexus of glutathione transferases and epoxide hydrolases in a metalloenzyme superfamily, Methods Enzymol. 401, 367-379.
108. Romero, L., Andrews, K., Ng, L., O'Rourke, K., Maslen, A., Kirby, G., 2006. Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. Biochem. J. 400, 135-141.
109. Saharan, S., Mandal, P.K., 2014. The emerging role of glutathione in Alzheimer's disease. J. Alzheimers Dis. 40,519-529.
110. Salminen, L.E., Paul, R.H., 2014. Oxidative stress and genetic markers of suboptimal antioxidant defense in the aging brain: a theoretical review. Rev. Neurosci. 25, 805-819.
111. Satoh, T., McKercher, S.R., Lipton, S.A., 2014. Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic. Biol. Med. 66:45-57.
112. Schmuck, E.M., Board, P.G., Whitbread, A.K., Tetlow, N., Cavanaugh, J.A., Blackburn, A.C., et al., 2005. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases. Pharmacogenet. Genomics 15, 493-501.
113. Sebastião I., Candeias, E., Santos, M.S., de Oliveira, C.R., Moreira, P.I., Duarte, A.I., 2014. Insulin as a bridge between type 2 diabetes and Alzheimer disease - how anti-diabetics could be a solution for dementia. Front Endocrinol. (Lausanne) 110, 1-13.
114. Shang, W., Liu, W.H., Zhao, X.E., Sun, Q.J., Bi, Z.J., and Chi, Z.F., 2008. Expressions of glutathione S-transferase alpha, mu, and pi in brains of medically intractable epileptic patients. BMC Neurosci. 9:67, 1-5.
115. Shao, L., Cui, J., Young, L.T., andWang, J.F., 2008. The effect of mood stabilizer lithium on expression and activity of glutathione S-transferases. Neuroscience 151, 518-524.
116. Shi, M., Bradner, J., Bammler, T.K., Eaton, D.L., Zhang, J.P., Ye, Z.C., et al., 2009. Identification of Glutathione S-transferase pi as a protein involved in Parkinson disease progression. Am. J. Pathol. 175, 54-65.
117. Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., et al., 1994. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348-355.
118. Sidell, K.R., Montine, K.S., Picklo, M.J. Sr., Olsen, S.J., Amarnath, V., Montine, T.J., 2003. Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum. J. Neuropathol. Exp. Neurol. 62, 146-153.
119. Singh, M., Khan, A.J., Shah, P.P., Shukla, R., Khanna, V.K., Parmar, D., 2008. Polymorphism in environment responsive genes and association with Parkinson disease. Mol. Cell. Biochem. 312:131-138.
120. Smeyne, M., Smeyne, R.J., 2013. Glutathione metabolism and Parkinson's disease. Free Radic. Biol. Med. 62, 13-25.
121. Smeyne, M., Boyd, J., Raviie Shepherd, K., Jiao, Y., Pond, B.B., Hatler, M., et al., 2007. GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 104, 1977-1982.
122. Spalletta, G., Bernardini, S., Bellincampi, L., Federici, G., Trequattrini, A., Ciappi, F., et al., 2007. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease. Am. J. Geriatr. Psychiatry 15, 879-887.
123. Spencer, J.P., Jenner, A., Aruoma, O.I., Evans, P.J., Kaur, H., Dexter, D.T., et al., 1994. Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease. FEBS Lett. 353, 246-250.
124. Stroombergen, M.C., Waring, R.H., 1999. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum. Exp. Toxicol. 18, 141-145.
125. Sugawara, T., Chan, P.H., 2003. Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid. Redox Signal. 5, 597-607.
126. Sultana, R., Butterfield, D.A., 2004. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products. Neurochem. Res. 29, 2215-2220.
127. Sun, K.H., Chang, K.H., Clawson, S., Ghosh, S., Mirzaei, H., Regnier, F., et al., 2011. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J. Neurochem. 118, 902-914.
128. Tansey, F.A., Cammer, W., 1991. A pi form of glutathione S-transferase is amyelin-and oligodendrocyte-associated enzyme in mouse brain. J. Neurochem. 57, 95-102.
129. Tchaikovskaya, T., Fraifeld, V., Urphanishvili, T., Andorfer, J.H., Davies, P., Listowsky, I., 2005. Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease. Mech. Ageing Dev. 126, 309-315.
130. 2+ leak in chronic heart failure, Circ. Res. 103, 1466-1472.
131. Torres, L.L., Quaglio, N.B., de Souza, G.T., Garcia, R.T., Dati, L.M., Moreira, W.L., et al., 2011. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 26, 59-68.
132. Townsend, D.M., Manevich, Y., He, L., Hutchens, S., Pazoles, S.J., Tew, K.D., 2009. Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress, J. Biol. Chem. 284, 436-445.
133. Trauner, M., Nathanson, M.H., Mennone, A., Rydberg, S.A., Boyer, J.L., 1997. Nitric oxide donors stimulate bile flow and glutathione disulfide excretion independent of guanosine 3′,5′-cyclic monophosphate in the isolated perfused rat liver. Hepatology, 25, 263-269.
134. Vasieva O., 2011. The many faces of glutathione transferase pi. Curr. Mol. Med. 11, 129-139.
135. Velu, C.S., Niture, S.K., Doneanu, C.E., Pattabiraman, N., Srivenugopal, K.S., 2007. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46, 7765-7780.
136. Venkateshappa, C., Harish, G., Mahadevan, A., Srinivas Bharath, M.M., Shankar, S.K., 2012. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease. Neurochem. Res. 37, 1601-1614.
137. Vilar, R., Coelho, H., Rodrigues, E., Gama, M.J., Rivera, I., Taioli, E., et al., 2007. Association of A313 G polymorphism (GSTP1∗B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease. Eur. J. Neurol. 14, 156-161.
138. Wahid, M., Mahiabeen, I., Baig, R.M. Kayani, M.A., 2013. Expression of CYP1A1 and GSTP1 in human brain tumor tissues in Pakistan. Asian Pac. J. Cancer Prev. 14, 7187-7191.
139. Wang, J., Boja, E.S., Tan, W., Tekle, E., Fales, H.M., English, S., et al., 2001a. Reversible glutathionylation regulates actin polymerization in A431 cells. J. Biol. Chem. 276, 47763-47766.
140. Wang, J., Tan, L., Wang, H.F., Tan, C.C., Meng, X.F., Wang, C., et al., 2015. Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis. J. Alzheimer's Dis. 44, 385-396.
141. Wang, T., Arifoglu, P., Ronai, Z., Tew, K.D., 2001b. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J. Biol. Chem. 276, 20999-21003.
142. Whitworth, A.J., Theodore, D.A., Greene, J.C., Benes, H., Wes, P.D., Pallanck, L.J., 2005. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 102, 8024-8029.
143. Wilce, M.C., Parker, M.W., 1994. Structure and function of glutathione S-transferases. Biochim. Biophys. Acta 1205:1-18.
144. Wu, B., Dong, D., 2012. Human cytosolic glutathione transferases: structure, function, and drug discovery. Trends Pharmacol. Sci. 33,656-668.
145. Wu, Y., Fan, Y., Xue, B., Luo, L., Shen, J., Zhang, S., et al., 2006. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25, 5787-5800.
146. Xie, C., Lovell, M.A., Markesbery, W.R., 1998. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Radic. Biol. Med. 25, 979-988.
147. Yang Y., Sharma, R., Zimniak, P., Awasthi, Y.C., 2002. Role of α class glutathione S-transferases as antioxidant enzymes in rodent tissues. Toxicol. Appl. Pharmacol.182,105-115.
148. Zhang, J., Grek, C., Ye, Z.W., Manevich, Y., Tew, K.D., Townsend, D.M., 2014. Pleiotropic functions of glutathione s-transferase P. Adv. Cancer Res. 122, 143-175.
149. Zhou, H., Brock, J., Casarotto, M.G., Oakley, A.J., Board, P.G., 2011. Novel folding and stability defects cause a deficiency of human glutathione transferase omega 1. J. Biol. Chem. 286, 4271-4279.